Traitement par injections d'acide polylactique (Newfill®) des lipoatrophies faciales chez les malades infectés par le VIH

Treatment of facial lipoatrophy in HIV patients by injection of polylactic acid (Newfill®) was shown to be efficacious in the majority of subjects. Training in the administration of this treatment is needed to ensure optimal efficacy and safety. A number of technical difficulties led to changes in treatment methods, i.e. routine adoption of a mask and protective glasses and use of a Luer-lock syringe due to blockage of syringes in more than 20% of cases, with splashing; increase in dilution volume from 3 to 5 ml; use of a centrifuge to ensure greater homogeneity of the solution; use of lidocaine in place of water for injections in order to reduce pain for patients.